Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) EBITDA (2021 - 2025)

Historic EBITDA for Tenon Medical (TNON) over the last 5 years, with Q3 2025 value amounting to -$3.3 million.

  • Tenon Medical's EBITDA fell 486.81% to -$3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.8 million, marking a year-over-year increase of 592.6%. This contributed to the annual value of -$13.6 million for FY2024, which is 1223.67% up from last year.
  • According to the latest figures from Q3 2025, Tenon Medical's EBITDA is -$3.3 million, which was down 486.81% from -$2.8 million recorded in Q2 2025.
  • In the past 5 years, Tenon Medical's EBITDA ranged from a high of -$201000.0 in Q1 2021 and a low of -$7.8 million during Q4 2022
  • In the last 5 years, Tenon Medical's EBITDA had a median value of -$3.2 million in 2022 and averaged -$3.4 million.
  • Its EBITDA has fluctuated over the past 5 years, first plummeted by 107064.68% in 2022, then soared by 6072.48% in 2023.
  • Tenon Medical's EBITDA (Quarter) stood at -$2.8 million in 2021, then plummeted by 175.76% to -$7.8 million in 2022, then skyrocketed by 60.72% to -$3.1 million in 2023, then fell by 0.29% to -$3.1 million in 2024, then decreased by 8.16% to -$3.3 million in 2025.
  • Its EBITDA stands at -$3.3 million for Q3 2025, versus -$2.8 million for Q2 2025 and -$3.6 million for Q1 2025.